Peripheral Exudative Hemorrhagic Chorioretinopathy with Clinical Presentation Similar to Choroidal Melanoma: Case Report
DOI:
https://doi.org/10.48560/rspo.44822Keywords:
Choroid Diseases, Multimodal Imaging, Retinal Diseases, Retinal HemorrhageAbstract
Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) is a rare degenerative retinal disorder characterized by peripheral hemorrhagic and exudative lesions that frequently mimic choroidal melanoma and other intraocular tumors. We report a case of a 78-year-old male with initial suspicion of choroidal melanoma, ultimately diagnosed as PEHCR following multimodal imaging. This report highlights the diagnostic challenges posed by PEHCR, the fundamental role of advanced imaging techniques, and the importance of a conservative management approach in most cases. A brief review of the literature is provided to contextualize the clinical, imaging, and therapeutic features of this underrecognized entity.
Downloads
References
Larrea J, Sanchez-Avila RM, Villota-Deleu E, Fernandez-Vega Sanz A. Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy in a referral center in Spain. Arch Soc Esp Oftalmol. 2022;97:201-10. doi: 10.1016/j.oftale.2022.04.002.
Sodhi GS, Singh N, Wrenn J, Singh AD. Peripheral hemorrhagic chorioretinopathy: differentiating features from choroidal melanoma. Ocul Oncol Pathol. 2023;9:1-8. doi:10.1159/000528663.
Reese AB, Jones IS. Hemorrhagic detachment of the pigment epithelium of the retina. Trans Am Acad Ophthalmol Otolaryngol. 1962;66:471-9.
Badawi AH, Semidey VA, Magliyah M, Al-Dhibi H. Updated systematic review and clinical spectrum of peripheral exudative hemorrhagic chorioretinopathy. Middle East Afr J Ophthalmol. 2020;27:4-9. doi:10.4103/meajo.MEAJO_85_20.
Elwood KF, Richards PJ, Schildroth KR, Mittleu M. Peripheral exudative hemorrhagic chorioretinopathy (PEHCR): diagnostic and therapeutic challenges. Medicina. 2023;59:1507. doi:10.3390/medicina5901507.
Kim YT, Kang SW, Lee JH, Chung SE. Peripheral exudative hemorrhagic chorioretinopathy in Korean patients. Jpn J Ophthalmol. 2010;54:227-31. doi: 10.1007/s10384-009-0794-0.
Safir M, Zloto O, Fabian ID, Moroz I, Gaton DD, Vishnevskia-Dai V. Peripheral exudative hemorrhagic chorioretinopathy with and without treatment: clinical and multimodal imaging characteristics and prognosis. PLoS One. 2022;17:e0275163. doi:10.1371/journal.pone.0275163.
Shields CL, Salazar PF, Mashayekhi A, Shields JA. Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes. Ophthalmology. 2009;116:529-35. doi: 10.1016/j.ophtha.2008.10.015.
Seibel I, Hager A, Duncker T, Riechardt AI, Nurnberg D, Klein JP, et al. Anti-VEGF therapy in symptomatic peripheral exudative hemorrhagic chorioretinopathy (PEHCR) involving the macula. Graefes Arch Clin Exp Ophthalmol. 2016;254:653-9. doi:10.1007/s00417-015-3096-x.
Malcles A, Russo A, Agard E, El-Chehab H, Dot C. Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of Aflibercept: report of 4 cases. Acta Ophthalmol. 2015;93:e596-7. doi:10.1111/j.1755-3768.2015.0671.
Takayama K, Enoki T, Kojima T, Ishikawa S, Takeuchi M. Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab. Clin Ophthalmol. 2012;6:865-9. doi:10.2147/OPTH.S31640.
Nicolò M, Ferro Desideri L, Vague A, Traverso CE. Faricimab: [reference truncated in the source document]
Koksaldi S, Karti O, Saatci AO. Anti-vascular endothelial growth factor therapies in ophthalmology. Med Hypotheses Discov Innov Ophthalmol. 2025;14:107-35. doi:10.51329/mehdiophthalm1526.
Arnold-Vangsted A, Schou MG, Balaratnasingam C, Riechardt AI, Nurnberg D, Klein JP, et al. Efficacy of intravitreal faricimab therapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis. Acta Ophthalmol. 2025;103:247-56. doi:10.1111/aos.16797.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista Sociedade Portuguesa de Oftalmologia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Do not forget to download the Authorship responsibility statement/Authorization for Publication and Conflict of Interest.
The article can only be submitted with these two documents.
To obtain the Authorship responsibility statement/Authorization for Publication file, click here.
To obtain the Conflict of Interest file, click here
